Gallium maltolate

Drug Profile

Gallium maltolate

Latest Information Update: 14 May 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Titan Pharmaceuticals
  • Class Antineoplastics; Heavy metals; Organometallic compounds; Pyrones; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Bacterial infections; Bone disorders; Cancer; Malignant hypercalcaemia; Osteitis deformans; Rheumatoid arthritis

Most Recent Events

  • 14 Mar 2006 Preclinical trials in Bacterial infections in USA (PO)
  • 11 Jul 2005 Data presented at the Annual European Congress of Rheumatology (EULAR-2005) have been added to the Rheumatic disease pharmacodynamics section
  • 22 Mar 2005 Preclinical data from a media release have been added to the Rheumatic Disease pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top